Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Resident Physician

Internal Medicine · Singapore · 2022-10-12

Processing Time
317 days
Decision Date
2022-10-12
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue investigating genetic factors and underlying mechanisms that modulate patient health outcomes to devise systems-level methodologies for the diagnosis, treatment, and management of internal diseases. Her work specifically focuses on chromosomal stability and identifying centromeric locations of instability to develop targeted cancer therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on chromosomal stability is critical for cancer treatment and public health, supported by NIH funding.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 7 years of experience, a strong citation record of 112, and a history of published research in peer-reviewed journals.

3 Waiver Benefit Met

On balance, her contributions to cancer research and internal medicine justify waiving the job offer requirement for the benefit of U.S. healthcare.

Why This Petition Was Approved

The case was approved based on the petitioner's 7 years of research experience, 2 peer-reviewed journal articles, and 2 abstracts which garnered 112 citations. Additionally, the national importance was underscored by funding from the National Institutes of Health (NIH) and the March of Dimes Foundation, alongside 4 expert recommendation letters.

Request for Evidence (RFE)

Successfully Addressed

An RFE was issued during the processing of the case; the legal team responded with additional evidence to clarify the petitioner's qualifications and the importance of her work, leading to approval.

RFE Targets
prong 1 national importanceprong 2 well positioned

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Maryland 76 days 2022-04-16
The petitioner proposes to utilize her expertise in advanced molecular, chromosomal, and DNA tools to investigate the mechanisms of chromosomal rearrangement that drive cancer. Her work focuses on identifying novel therapies for aggressive forms of pediatric cancer, such as malignant rhabdoid tumors, and developing castrate-resistant prostate cancer lines to study molecular mechanisms of resistance.
View Case

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
108 days 2022-03-21
The petitioner proposes to continue his research investigating the molecular mechanisms behind genetic disorders, inflammation-associated disorders, and cancers. This work aims to facilitate the development of novel treatments and deepen the scientific understanding of these conditions to provide new therapeutic avenues.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
195 days 2022-05-06
The petitioner proposes to continue developing genomic screening platforms and gene therapy-based approaches to facilitate the design of novel treatment modalities for cancer. This work focuses on identifying genetic factors that contribute to cancer development and progression using state-of-the-art molecular methods.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Singapore

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-10-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 317 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Singapore All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist